← Back to directory

Claus Belka

Researcher Next ID · RN-032166

Researcher · Medicine

LMU Klinikum

Munich, Germany

Accepting doctoral researchersFunding unknown
Works count
1,472
Citation count
27,864
H-index
85
i10-index
492

Research interests

Medicine
Physics and Astronomy
Advanced Radiotherapy Techniques
Head and Neck Cancer Studies
Lung Cancer Diagnosis and Treatment
Radiomics and Machine Learning in Medical Imaging
Medical Imaging Techniques and Applications

Publications

  • ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma

    Radiotherapy and Oncology · 2023 · 10.1016/j.radonc.2023.109663

  • Current status and recent advances in reirradiation of glioblastoma

    Radiation Oncology · 2021 · 10.1186/s13014-021-01767-9

  • First Clinical Results for PSMA-Targeted α-Therapy Using 225Ac-PSMA-I&T in Advanced-mCRPC Patients

    Journal of Nuclear Medicine · 2020 · 10.2967/jnumed.120.251017

  • Radiation-induced lung toxicity – cellular and molecular mechanisms of pathogenesis, management, and literature review

    Radiation Oncology · 2020 · https://doi.org/10.1186/s13014-020-01654-9

  • Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement

    Radiotherapy and Oncology · 2020 · https://doi.org/10.1016/j.radonc.2020.04.001

  • Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches

    Radiation Oncology · 2019 · https://doi.org/10.1186/s13014-019-1345-6

  • MR-guidance in clinical reality: current treatment challenges and future perspectives

    Radiation Oncology · 2019 · https://doi.org/10.1186/s13014-019-1308-y

  • Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer—The ETOP NICOLAS trial

    Lung Cancer · 2019 · 10.1016/j.lungcan.2019.05.001

  • Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma

    JAMA Oncology · 2018 · https://doi.org/10.1001/jamaoncol.2017.4996

  • A comparative study of machine learning methods for time-to-event survival data for radiomics risk modelling

    Scientific Reports · 2017 · https://doi.org/10.1038/s41598-017-13448-3

  • Abscopal, immunological effects of radiotherapy: Narrowing the gap between clinical and preclinical experiences

    Immunological Reviews · 2017 · 10.1111/imr.12573

  • ESTRO-ACROP guideline “target delineation of glioblastomas”

    Radiotherapy and Oncology · 2016 · https://doi.org/10.1016/j.radonc.2015.12.003

  • Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine–DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial

    Journal of Clinical Oncology · 2016 · 10.1200/jco.2015.63.4691

  • CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG)

    International Journal of Cancer · 2015 · https://doi.org/10.1002/ijc.29683

  • Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non–Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE)

    Journal of Clinical Oncology · 2015 · https://doi.org/10.1200/jco.2015.62.6812

  • Current concepts in clinical radiation oncology

    Radiation and Environmental Biophysics · 2013 · 10.1007/s00411-013-0497-2

  • Dying cell clearance and its impact on the outcome of tumor radiotherapy

    Frontiers in Oncology · 2012 · 10.3389/fonc.2012.00116

  • A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck

    BMC Cancer · 2006 · https://doi.org/10.1186/1471-2407-6-28

  • Guardians of cell death: the Bcl-2 family proteins

    Essays in Biochemistry · 2003 · 10.1042/bse0390073

  • Apoptotic Cells Induce Migration of Phagocytes via Caspase-3-Mediated Release of a Lipid Attraction Signal

    Cell · 2003 · https://doi.org/10.1016/s0092-8674(03)00422-7

  • Rapid extracellular release of cytochrome c is specific for apoptosis and marks cell death in vivo

    Blood · 2001 · 10.1182/blood.v98.5.1542

  • Radiation induced CNS toxicity – molecular and cellular mechanisms

    British Journal of Cancer · 2001 · 10.1054/bjoc.2001.2100

  • Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis

    Oncogene · 2000 · 10.1038/sj.onc.1203824

  • Stimulation of CD95 (Fas) blocks T lymphocyte calcium channels through sphingomyelinase and sphingolipids

    Proceedings of the National Academy of Sciences · 1999 · 10.1073/pnas.96.24.13795

  • Lipopolysaccharide Activates Caspase-1 (Interleukin-1–Converting Enzyme) in Cultured Monocytic and Endothelial Cells

    Blood · 1998 · 10.1182/blood.v91.2.577

Current projects

    No projects listed.